|
Laxman Pai, Opalesque Asia: VC investment in the Americas fell from $58.6 billion across 4,104 deals in Q2'24 to $41.4 billion across 3,124 deals in Q3'24. The US accounted for a large majority of this total-$37.5 billion across 2,794 deals, said a study.
According to KPMG Private Enterprise's Venture Pulse report, despite continued uncertainty in the market, AI continued to see incredibly strong VC investment in the US during Q3'24, led by a $1.5 billion raise by AI-powered defense solutions company Anduril Industries and a $1 billion raise by core AI-focused startup Safe Superintelligence.
A wide range of other AI-focused startups also raised $100 million+ funding rounds during the quarter, including Gen AI-focused chip developer Groq ($640 million), immersive technologies company Infinite Reality ($350 million), data infrastructure company Cribl ($319 million), AI-focused surgical solutions company Caresyntax ($310 million), and airline retail platform Flyr ($295 million).
Life sciences also attracted large deals, including a $370 million raise by autoimmune disease-focused Candid Therapeutics, a $350 million raise by weight loss drug company Metsara, and a $325 million raise by programable cell cancer therapies company ArsenalBio.
Meanwhile, given the uncertain economic environment and the sustained lack of exit activity, VC investors prioritized deal due diligence during Q3'24, taking a deeper look into pathways to profitability, EBITA targets, growth ex...................... To view our full article Click here
|
RSS
